Targeting CXCR1 and CXCR2 to overcome radiotherapy resistance in PTEN-deficient prostate carcinoma (2020)
Attributed to:
The central importance of CXCL8 signaling to inflammatory-based tumour initiation and invasive prostate carcinoma.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.03.16.993394
Publication URI: http://dx.doi.org/10.1101/2020.03.16.993394
Type: Preprint